These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 7577915)

  • 1. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering a novel specificity in subtilisin BPN'.
    Rheinnecker M; Baker G; Eder J; Fersht AR
    Biochemistry; 1993 Feb; 32(5):1199-203. PubMed ID: 8448130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of subtilisin BPN' with altered specificity profiles.
    Rheinnecker M; Eder J; Pandey PS; Fersht AR
    Biochemistry; 1994 Jan; 33(1):221-5. PubMed ID: 8286344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complete amino acid substitutions at position 131 that are positively involved in cold adaptation of subtilisin BPN'.
    Taguchi S; Komada S; Momose H
    Appl Environ Microbiol; 2000 Apr; 66(4):1410-5. PubMed ID: 10742220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtilisin BPN' variants: increased hydrolytic activity on surface-bound substrates via decreased surface activity.
    Brode PF; Erwin CR; Rauch DS; Barnett BL; Armpriester JM; Wang ES; Rubingh DN
    Biochemistry; 1996 Mar; 35(10):3162-9. PubMed ID: 8605150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the mechanism and improving the rate of substrate-assisted catalysis in subtilisin BPN'.
    Carter P; Abrahmsén L; Wells JA
    Biochemistry; 1991 Jun; 30(25):6142-8. PubMed ID: 2059622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants.
    Li Y; Hu Z; Jordan F; Inouye M
    J Biol Chem; 1995 Oct; 270(42):25127-32. PubMed ID: 7559646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering subtilisin BPN' for site-specific proteolysis.
    Carter P; Nilsson B; Burnier JP; Burdick D; Wells JA
    Proteins; 1989; 6(3):240-8. PubMed ID: 2516317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtilisin Sendai from alkalophilic Bacillus sp.: molecular and enzymatic properties of the enzyme and molecular cloning and characterization of the gene, aprS.
    Yamagata Y; Isshiki K; Ichishima E
    Enzyme Microb Technol; 1995 Jul; 17(7):653-63. PubMed ID: 7605625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between S1 and S4 subsites in Kex2 protease: Kex2 exhibits dual specificity for the P4 side chain.
    Rockwell NC; Fuller RS
    Biochemistry; 1998 Mar; 37(10):3386-91. PubMed ID: 9521659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding of subtilisin BPN': role of the pro-sequence.
    Eder J; Rheinnecker M; Fersht AR
    J Mol Biol; 1993 Sep; 233(2):293-304. PubMed ID: 8377204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of renaturation of subtilisin BPN' by a novel procedure using organic salts and a digestible mutant of Streptomyces subtilisin inhibitor.
    Matsubara M; Kurimoto E; Kojima S; Miura K; Sakai T
    FEBS Lett; 1994 Apr; 342(2):193-6. PubMed ID: 8143876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.